Professional background

Dr Susie Morris is a consultant dermatologist and honorary senior lecturer at UCLH. She has a special interest in autoimmune disease and leads the combined dermatology/rheumatology clinic, a tertiary referral service. In addition, she sees general dermatology and skin cancer patients.

Dr Morris graduated from University College London and Middlesex school of Medicine, with Distinction in Surgery, and undertook her dermatology training at the St John’s Institute of Dermatology (St Thomas’s). Her doctoral thesis was in the field of cellular protection at University College London.

Dr Morris is a full member of the British Association of Dermatology (BAD), St John’s Institute of Dermatology Society, The American Academy of Dermatology and a fellow of the Royal College of Physicians (FRCP).

Research interests

Autoimmune disease


SC Hofmann1,2, MJ Leandro1, SD Morris3 and DA Isenberg1 Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus – report of 17 cases and review of the literature. Lupus (2013) 0, 1–8

Deterioration of Vitiligo and new onset of Halo naevi observed in two patients receiving Adalimumab (THERAPEUTIC HOTLINE). 2013 BJD

Marruthapppu T, Morris S. Dermatol Ther. 2013 Jul;26(4):370-2Marruthapppu T, Morris S. Vitiligo and Halo Naevi following treatment with Adalimumab in two patients. BJD July 2011. abstr

Agar N, Morris S, Russell-Jones R, Hawk J, Whittaker S. Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol. 2009 Mar;160(3):698-703. Epub 2008 Dec 5.

Edmonds EV, Morris SD, Short K, Bewley SJ, Eady RA. Pustular psoriasis of pregnancy treated with ciclosporin and high-dose prednisolone.Clin Exp Dermatol. 2005 Nov;30(6):709-10.

K Harman, SD Morris, EM Higgins. Prolonged anticonvulsant hypersensitivity syndrome. Brit J Dermatol, 2003 Jul;28(4):364-5.Morris SD. Heat shock proteins in the skin. Invited editorial for Clinical and Experimental Dermatology 2002;27:220-224.

Morris SD, Rycroft RJG, White IR, Wakelin SH, McFadden JP. Comparative frequency of patch test reactions to topical antibiotics. Brit J Dermatol, 2002:146;1047-1051.

Morris SD, Hawk J, Elder G, Sarkany R. Ferrochelatase gene polymorphism analysis for accurate genetic counselling in erythropoeitic protoporphyria. Brit J Dermatol, 2002;147(3): 572-574.

Morris SD, Mallipeddi R, Oyama N, Gratian MJ, Harman KE, Bhogal BS, Black MM, Eady RA, Hashimoto T,1 McGrath JA. Psoraisis bullosa acquisita. Clinical and Experimental Dermatology, 2002:27:665-9.

Morris SD, Cerio R, Paige D. An unusual presentation of diffuse granuloma annulare in an HIV positive patient. Immunohistochemical evidence of predominant CD8 lymphocytes. Clinical and Exp Dermatol, 2002;27:205-208

Morris SD, Robson A, Calonje E. Fibrous hamartoma of childhood. Clin and Exp Dermatol, 2002;27(6):533-4.

Keane FM, Morris SD, Smith HR, Rycroft RJG. Allergy in coronary in-stent restenosis. Lancet 2001;357:1205.

Morris SD, McGibbon DH, Rycroft RJG. Dermatitis caused by electromagnetic radiation. Contact Dermatitis 2001;45(3):188.Morris SD, Onadim Z, Yu R. A case of sebaceous nevus, meningioma, retinoblastoma and multiple lipomata. Brit J Dermatol July 2000;143:211-213.

Morris SD, Russell-Jones R, Hawk JML, Whittaker S. Four patients with eythrodermic CTCL and CAD. Arch Dermatol, in press.Morris SD, Yellon DM. ACE inhibitors potentiate preconditioning via bradykinin B2 receptors in the human heart. J Am Coll Cardiol 1997;29:1599-606.

18. Morris S.D, Cumming DVE, Latchman DS, Yellon DM. Specific induction of 70kDa hsps by Herbimycin-A protects cardiomyocytes: A pharmacological route to cytoprotection. J Clin Invest 1996;97:706-712.